ÅǸ޴º
Á¦¸ñ | PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer. Oncotarget 2017 (IF 5.168) | µî·ÏÀÏ | 20171211 | ´Ù¿î·Îµå | |
---|---|---|---|---|---|
Kim C, Lee C, Chon HJ, Kim JH, Park HS, Heo SJ, Kim HJ, Kim TS, Kwon WS, Chung HC, Rha SY.
PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer. Oncotarget 2017 |
Copyright ¨Ï chamc, All rights reserved.